Rezultati - Eunice L. Kwak

Refine Results
  1. 1
    Role for NF-κB in the Regulation of Ferritin H by Tumor Necrosis Factor-α

    Role for NF-κB in the Regulation of Ferritin H by Tumor Necrosis Factor-α od Eunice L. Kwak, Denis A. Larochelle, Carole Beaumont, Suzy V. Torti, Frank M. Torti

    Izdano 1995
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    First-in-Human Phase I Dose Escalation Study of a Second-Generation Non-Ansamycin HSP90 Inhibitor, AT13387, in Patients with Advanced Solid Tumors

    First-in-Human Phase I Dose Escalation Study of a Second-Generation Non-Ansamycin HSP90 Inhibitor, AT13387, in Patients with Advanced Solid Tumors od Geoffrey I. Shapiro, Eunice L. Kwak, Bruce J. Dezube, Murray Yule, John Ayrton, John F. Lyons, Daruka Mahadevan

    Izdano 2014
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Familial Gastric Cancers

    Familial Gastric Cancers od Namrata Setia, Jeffrey W. Clark, Dan G. Duda, Theodore S. Hong, Eunice L. Kwak, John T. Mullen, Gregory Y. Lauwers

    Izdano 2015
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Rapid Radiographic and Clinical Improvement After Treatment of a <i>MET</i>-Amplified Recurrent Glioblastoma With a Mesenchymal-Epithelial Transition Inhibitor

    Rapid Radiographic and Clinical Improvement After Treatment of a <i>MET</i>-Amplified Recurrent Glioblastoma With a Mesenchymal-Epithelial Transition Inhibitor od S. Andrew, Tracy T. Batchelor, Eunice L. Kwak, Jeffrey W. Clark, Daphne L. Wang, Keith D. Wilner, David N. Louis, A. John Iafrate

    Izdano 2011
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Dose-Painted Intensity-Modulated Radiation Therapy for Anal Cancer: A Multi-Institutional Report of Acute Toxicity and Response to Therapy

    Dose-Painted Intensity-Modulated Radiation Therapy for Anal Cancer: A Multi-Institutional Report of Acute Toxicity and Response to Therapy od Lisa A. Kachnic, Henry Tsai, John J. Coen, Lawrence S. Blaszkowsky, Kevan L. Hartshorn, Eunice L. Kwak, John Willins, David P. Ryan, Theodore S. Hong

    Izdano 2010
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    Capecitabine Plus Erlotinib in Gemcitabine-Refractory Advanced Pancreatic Cancer

    Capecitabine Plus Erlotinib in Gemcitabine-Refractory Advanced Pancreatic Cancer od Matthew H. Kulke, Lawrence S. Blaszkowsky, David P. Ryan, Jeffrey W. Clark, Jeffrey A. Meyerhardt, Andrew X. Zhu, Peter C. Enzinger, Eunice L. Kwak, Alona Muzikansky, Colleen Lawrence, Charles S. Fuchs

    Izdano 2007
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors

    Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors od Geoffrey I. Shapiro, Jordi Rodón, Cynthia Bedell, Eunice L. Kwak, José Baselga, Irene Braña, Shuchi S. Pandya, Christian Scheffold, A. Douglas Laird, Linh T. Nguyen, Yi Xu, Coumaran Égile, Gerald M. Edelman

    Izdano 2013
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    A protein and mRNA expression-based classification of gastric cancer

    A protein and mRNA expression-based classification of gastric cancer od Namrata Setia, Agoston T. Agoston, Hye Seung Han, John T. Mullen, Dan G. Duda, Jeffrey W. Clark, Vikram Deshpande, Mari Mino‐Kenudson, Amitabh Srivastava, Jochen K. Lennerz, Theodore S. Hong, Eunice L. Kwak, Gregory Y. Lauwers

    Izdano 2016
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Panitumumab in Patients with KRAS Wild-Type Colorectal Cancer after Progression on Cetuximab

    Panitumumab in Patients with KRAS Wild-Type Colorectal Cancer after Progression on Cetuximab od Raymond Wadlow, Aram F. Hezel, Thomas A. Abrams, Lawrence S. Blaszkowsky, Charles S. Fuchs, Matthew H. Kulke, Eunice L. Kwak, Jeffrey A. Meyerhardt, David P. Ryan, Jackie Szymonifka, Brian M. Wolpin, Andrew X. Zhu, Jeffrey W. Clark

    Izdano 2011
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    Updated long‐term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Massachusetts General Hospital, 1978 to 2010

    Updated long‐term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Massachusetts Ge... od Sophie Cai, Theodore S. Hong, Saveli Goldberg, Carlos Fernández‐del Castillo, Sarah P. Thayer, Cristina R. Ferrone, David P. Ryan, Lawrence S. Blaszkowsky, Eunice L. Kwak, Christopher G. Willett, Keith D. Lillemoe, Andrew L. Warshaw, Jennifer Y. Wo

    Izdano 2013
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    Rapid and Dramatic Radiographic and Clinical Response to an ALK Inhibitor (Crizotinib, PF02341066) in an ALK Translocation-Positive Patient with Non-small Cell Lung Cancer

    Rapid and Dramatic Radiographic and Clinical Response to an ALK Inhibitor (Crizotinib, PF02341066) in an ALK Translocation-Positive Patient with Non-small Cell Lung Cancer od Sai‐Hong Ignatius Ou, Lyudmila Bazhenova, D. Ross Camidge, Benjamin Solomon, June Herman, Tatiana S. Kain, Yung‐Jue Bang, Eunice L. Kwak, Alice T. Shaw, Ravi Salgia, Robert G. Maki, Jeffrey W. Clark, Keith D. Wilner, A. John Iafrate

    Izdano 2010
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    Phase I Study of AMG 337, a Highly Selective Small-molecule MET Inhibitor, in Patients with Advanced Solid Tumors

    Phase I Study of AMG 337, a Highly Selective Small-molecule MET Inhibitor, in Patients with Advanced Solid Tumors od David S. Hong, Patricia LoRusso, Omid Hamid, Filip Janků, Muaiad Kittaneh, Daniel V.T. Catenacci, Emily Chan, Tanios Bekaii‐Saab, Shirish M. Gadgeel, Robert D. Loberg, Benny Amore, Yuying C. Hwang, Rui Tang, Gataree Ngarmchamnanrith, Eunice L. Kwak

    Izdano 2018
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    Isolation of rare circulating tumour cells in cancer patients by microchip technology

    Isolation of rare circulating tumour cells in cancer patients by microchip technology od Sunitha Nagrath, Lecia V. Sequist, Shyamala Maheswaran, Daphne W. Bell, Daniel Irimia, Lindsey Ulkus, Matthew R. Smith, Eunice L. Kwak, Subba R. Digumarthy, Alona Muzikansky, Paula D. Ryan, Ulysses J. Balis, Ronald G. Tompkins, Daniel A. Haber, Mehmet Toner

    Izdano 2007
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    Molecular Heterogeneity and Receptor Coamplification Drive Resistance to Targeted Therapy in<i>MET</i>-Amplified Esophagogastric Cancer

    Molecular Heterogeneity and Receptor Coamplification Drive Resistance to Targeted Therapy in<i>MET</i>-Amplified Esophagogastric Cancer od Eunice L. Kwak, Leanne G. Ahronian, Giulia Siravegna, Benedetta Mussolin, Darrell R. Borger, Jason T. Godfrey, Nicholas A. Jessop, Jeffrey W. Clark, Lawrence S. Blaszkowsky, David P. Ryan, Jochen K. Lennerz, A. John Iafrate, Alberto Bardelli, Theodore S. Hong, Ryan B. Corcoran

    Izdano 2015
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  15. 15
    Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529

    Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529 od Devarati Mitra, Theodore S. Hong, Nora Horick, Brent S. Rose, Lorraine N. Drapek, Lawrence S. Blaszkowsky, Jill N. Allen, Eunice L. Kwak, Janet E. Murphy, Jeffrey W. Clark, David P. Ryan, James C. Cusack, Liliana Bordeianou, David L. Berger, Jennifer Y. Wo

    Izdano 2017
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  16. 16
    A First-in-Human, Phase I, Dose-Escalation Study of TAK-117, a Selective PI3Kα Isoform Inhibitor, in Patients with Advanced Solid Malignancies

    A First-in-Human, Phase I, Dose-Escalation Study of TAK-117, a Selective PI3Kα Isoform Inhibitor, in Patients with Advanced Solid Malignancies od Dejan Juric, Johann S. de Bono, Patricia LoRusso, John Nemunaitis, Elisabeth I. Heath, Eunice L. Kwak, T. Macarulla Mercadé, Elena Geuna, Maria J. de Miguel, Chirag Patel, Keisuke Kuida, Serap Sankoh, Eric H. Westin, Fabian Zohren, Yaping Shou, Josep Tabernero

    Izdano 2017
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  17. 17
    <i>MET</i> Amplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib

    <i>MET</i> Amplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib od Jochen K. Lennerz, Eunice L. Kwak, A. B. Ackerman, Michael Michael, Stephen B. Fox, Kristin Bergethon, Gregory Y. Lauwers, James G. Christensen, Keith D. Wilner, Daniel A. Haber, Ravi Salgia, Yung‐Jue Bang, Jeffrey W. Clark, Benjamin Solomon, A. John Iafrate

    Izdano 2011
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  18. 18
    Phase 1/2 study of everolimus in advanced hepatocellular carcinoma

    Phase 1/2 study of everolimus in advanced hepatocellular carcinoma od Andrew X. Zhu, Thomas A. Abrams, Rebecca A. Miksad, Lawrence S. Blaszkowsky, Jeffrey A. Meyerhardt, Hui Zheng, Alona Muzikansky, Jeffrey W. Clark, Eunice L. Kwak, Deborah Schrag, Kathryn R. Jors, Charles S. Fuchs, A. John Iafrate, Darrell R. Borger, David P. Ryan

    Izdano 2011
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  19. 19
    First-in-Human Study of PF-05212384 (PKI-587), a Small-Molecule, Intravenous, Dual Inhibitor of PI3K and mTOR in Patients with Advanced Cancer

    First-in-Human Study of PF-05212384 (PKI-587), a Small-Molecule, Intravenous, Dual Inhibitor of PI3K and mTOR in Patients with Advanced Cancer od Geoffrey I. Shapiro, Katherine M. Bell‐McGuinn, Julian R. Molina, Johanna C. Bendell, James Spicer, Eunice L. Kwak, Susan Pandya, Robert Millham, Gary Borzillo, Kristen J. Pierce, Lixin Han, Brett E. Houk, Jorge D. Gallo, María Alsina, Irene Braña, Josep Tabernero

    Izdano 2015
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  20. 20
    Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of ENMD-2076, a Novel Angiogenic and Aurora Kinase Inhibitor,in Patients with Advanced Solid Tumors

    Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of ENMD-2076, a Novel Angiogenic and Aurora Kinase Inhibitor,in Patients with Advanced Solid Tumors od Jennifer R. Diamond, Bruno R. Bastos, Ryan J. Hansen, Daniel L. Gustafson, S. Gail Eckhardt, Eunice L. Kwak, Shuchi S. Pandya, Graham C. Fletcher, Todd M. Pitts, Gillian N. Kulikowski, Mark Morrow, Jamie Arnott, Mark R. Bray, Carolyn Sidor, Wells A. Messersmith, Geoffrey I. Shapiro

    Izdano 2010
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: